Indication

Chronic Myeloid Leukemia - Accelerated Phase

2 clinical trials

2 products

Clinical trial

A Phase II Multi-center, Open Label Study of HQP1351 in Chinese Patients of Chronic Myeloid Leukemia With T315I Mutation in Accelerated Phase

Status: Active (not recruiting), Estimated PCD: 2024-04-01

Product

Clinical trial

Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT) Recipients With Hematologic Malignancies (HM)

Status: Recruiting, Estimated PCD: 2026-09-01

Product